Tin tức & Cập nhật

Older patients with cancer are unusually susceptible to polypharmacy, as well as potentially inappropriate medications and potential drug-drug interactions, reveals a study.

Treatment with thiazolidinedione (TZD) results in a significant decrease in mortality, cardiovascular events, and kidney-related adverse events among type 2 diabetes (T2D) patients with acute kidney disease (AKD), a recent study has shown.

Triplet therapy with belantamab mafodotin, bortezomib, and dexamethasone (BVd) significantly improves outcomes in relapsed or refractory multiple myeloma (RRMM), outperforming the daratumumab, bortezomib, and dexamethasone (DVd) combination therapy, according to the second interim analysis of the phase III DREAMM-7 trial.

In patients with rheumatoid arthritis (RA), high disease-associated central nervous system (CNS) pain activation on functional MRI (fMRI) brain scan may help predict clinical response to TNF inhibitor treatment, as shown in a phase III study.

New research in women with vaginal births has found a significant association between haemoglobin levels immediately after childbirth and the likelihood of developing symptoms of postpartum depression (PPD).

Drug therapy problems (DTPs), such as adverse drug reactions (ADRs), remain highly prevalent in children with acute lymphoblastic leukaemia (ALL), a study has found.

Radiologic imaging of high-risk cutaneous squamous cell carcinoma (sSCC) tumours displays unforeseen results such as local invasion and nodal metastasis, which result in changes in management in nearly half of these cases, reveals a study.

Treatment with abrocitinib or dupilumab results in the restoration of skin barrier function in patients with atopic dermatitis (AD), but these therapies show distinct proteomic impacts, according to a study.